NEW YORK (Reuters Health) Apr 17 - Use of once-daily tenofovir DF along with lamivudine or emtricitabine may be more effective than previous regimens for non-occupational postexposure prophylaxis (NPEP) in people at high risk for HIV infection, investigators report in the April 1st issue of the Journal of Acquired Immune Deficiency Syndromes.

Read the rest of this entry »